ArticleBlood advances2024

Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial.

Mehdi Hamadani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.